“…Histologically, both glandular and keratinizing squamous patterns are present. Squamous components are often negative for PSA and PSAP immunostains; patients with large squamous fractions may have normal PSA 3 , 4 . The tumors are usually large, sometimes replacing a substantial portion of the prostate.…”
Section: Discussionmentioning
confidence: 99%
“…Prostate ASC is clinically aggressive 2 . Locally advanced disease may be common at relatively low PSA levels depending on the extent of the squamous component 4 . Therefore, preoperative counseling regarding the possibility of adjacent organ involvement and need for extensive resection should be considered even if disease appears to be clinically localized.…”
Section: Discussionmentioning
confidence: 99%
“…There is a paucity of data regarding systemic chemotherapy or immunotherapy. While no regimens are currently recommended, 4 a recent case report demonstrated short-term response at 6 weeks to external beam radiation therapy (EBRT) and PD-1 inhibitor therapy in metastatic prostate ASC (Table 1).…”
Adenosquamous carcinoma is an extremely rare and lethal subtype of prostate cancer affecting an estimated 0.03 per million men annually. It has been associated with prior hormone therapy for prostate adenocarcinoma. We present a case of de novo adenosquamous carcinoma of the prostate treated with a multimodal approach including surgery, androgen-deprivation therapy, chemotherapy, and radiation.
“…Histologically, both glandular and keratinizing squamous patterns are present. Squamous components are often negative for PSA and PSAP immunostains; patients with large squamous fractions may have normal PSA 3 , 4 . The tumors are usually large, sometimes replacing a substantial portion of the prostate.…”
Section: Discussionmentioning
confidence: 99%
“…Prostate ASC is clinically aggressive 2 . Locally advanced disease may be common at relatively low PSA levels depending on the extent of the squamous component 4 . Therefore, preoperative counseling regarding the possibility of adjacent organ involvement and need for extensive resection should be considered even if disease appears to be clinically localized.…”
Section: Discussionmentioning
confidence: 99%
“…There is a paucity of data regarding systemic chemotherapy or immunotherapy. While no regimens are currently recommended, 4 a recent case report demonstrated short-term response at 6 weeks to external beam radiation therapy (EBRT) and PD-1 inhibitor therapy in metastatic prostate ASC (Table 1).…”
Adenosquamous carcinoma is an extremely rare and lethal subtype of prostate cancer affecting an estimated 0.03 per million men annually. It has been associated with prior hormone therapy for prostate adenocarcinoma. We present a case of de novo adenosquamous carcinoma of the prostate treated with a multimodal approach including surgery, androgen-deprivation therapy, chemotherapy, and radiation.
“…[4-6, 8, 9] Additionally, the squamous component can be differentiated by lack of staining with low molecular weight keratins, such as CAM 5.2 which will stain the glandular component. [6,9] Squamous cell carcinomas in the prostate have additionally been noted to stain positive with racemase/AMACR, but this is not helpful in determining the origin because cancers of urothelial origin also stain with AMACR. [5] Bassler [8] noted that in areas where adenocarcinoma and squamous components intermingled, the nuclei became larger and more pleomorphic like squamous carcinoma but maintained an immunohistochemical profile similar to adenocarcinoma.…”
Section: Discussionmentioning
confidence: 99%
“…[3] Prostate cancers with squamous differentiation frequently present with lower urinary tract symptoms, often without elevation of PSA. [9] Wang [2] suggests that squamous carcinomas, in contrast to adenocarcinomas, occur more often around the prostatic urethra as opposed to the peripheral zone. Therefore, most squamous carcinomas present with obstructive symptoms that are thus initially treated with transurethral resection of the prostate, which is how many of them are initially diagnosed.…”
We present a case of squamous cell carcinoma of the prostate, unique in that it was accompanied by a spatially separate focus of high-grade adenocarcinoma. Unlike previous case reports, the patient had no history of prior prostatic adenocarcinoma and had no history of treatment with antiandrogen or radiation therapy. Prostate carcinomas with squamous differentiation, while exceedingly rare, carry a poor prognosis compared to adenocarcinomas and should be considered in male patients with obstructive urinary symptoms without increased serum prostate specific antigen.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.